WARSAW — Nextremity Solutions, a strategic commercialization organization with a focus on the musculoskeletal space, located in The Orthopedic Capital of the World in Warsaw, announced it has received 510(k) clearance by the Food and Drug Administration to market its upcoming InCore Lapidus System. “We’re excited about the 510(k) clearance of our InCore Lapidus System,” …read more.

WARSAW — Nextremity Solutions Inc., a pure-play foot and ankle implant company located in “The Orthopedic Capital of the World” Warsaw, has been awarded, “2016 Entrepreneurial Firm of the Year” by the Kosciusko Chamber of Commerce. CEO and chairman of the board Nick Deeter and president Rod Mayer accepted the award. Nextremity Solutions was founded …read more.

WARSAW — Nextremity Solutions Inc., a surgeon-driven, pure-play foot and ankle orthopedic company located in Warsaw, announced it has received 510(k) approval by the Food & Drug Administration to market its upcoming Axi+Line Proximal Bunion Correction System. “The Axi+Line Proximal Bunion Correction System represents a significant advancement in the treatment of moderate to severe hallux valgus …read more.